Angioedema News and Research

RSS
Angioedema is the rapid swelling (edema) of the dermis, subcutaneous tissue, mucosa and submucosal tissues. It is very similar to urticaria, but urticaria, commonly known as hives, occurs in the upper dermis.
Dyax' Phase 3 hereditary angioedema clinical program affirms reliability of its novel PROs

Dyax' Phase 3 hereditary angioedema clinical program affirms reliability of its novel PROs

Medical institutes sponsor education newsletter series on angioedema

Medical institutes sponsor education newsletter series on angioedema

Merck update on the status of telcagepant clinical development programs

Merck update on the status of telcagepant clinical development programs

New Marketing Authorization Application for Rhucin submitted to the EMEA by Pharming

New Marketing Authorization Application for Rhucin submitted to the EMEA by Pharming

Cimzia approved for treating adult patients with rheumatoid arthritis

Cimzia approved for treating adult patients with rheumatoid arthritis

Cimzia approved in U.S. for rheumatoid arthritis

Cimzia approved in U.S. for rheumatoid arthritis

FDA grants priority review of Cinryze C1 inhibitor as treatment for acute attacks of hereditary angioedema

FDA grants priority review of Cinryze C1 inhibitor as treatment for acute attacks of hereditary angioedema

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Reactions to HPV vaccine Gardasil rare

Reactions to HPV vaccine Gardasil rare

ViroPharma Inc. submits sBLA for Cinryze to treat acute attacks of hereditary angioedema

ViroPharma Inc. submits sBLA for Cinryze to treat acute attacks of hereditary angioedema

FDA accepts filing and grants priority review for DX-88 for hereditary angioedema

FDA accepts filing and grants priority review for DX-88 for hereditary angioedema

FDA licenses for marketing Cinryze for hereditary angioedema

FDA licenses for marketing Cinryze for hereditary angioedema

FDA approves Actonel (risedronate sodium) for postmenopausal osteoporosis

FDA approves Actonel (risedronate sodium) for postmenopausal osteoporosis

Tredaptive and Janumet recommended for approval in European Union

Tredaptive and Janumet recommended for approval in European Union

Highly promising Alzheimer's and Parkinson's research

Highly promising Alzheimer's and Parkinson's research

Strange behaviours linked to popular sleeping pill Zolpidem

Strange behaviours linked to popular sleeping pill Zolpidem

Hope on the horizon for hereditary angioedema sufferers

Hope on the horizon for hereditary angioedema sufferers

Sedative-hypnotic drugs to get stronger warning labels

Sedative-hypnotic drugs to get stronger warning labels

Ryogen licenses gene patent to Invitrogen

Ryogen licenses gene patent to Invitrogen

Ryogen licenses gene patent to OriGene Technologies

Ryogen licenses gene patent to OriGene Technologies